Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system

TNM stage is not enough to accurately predict the prognosis of patients with non-small cell lung cancer (NSCLC). This study aimed to establish the immunological score (IS) in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), separately, and propose a new staging system in NSCLC. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Ziqing, Yang, Fan, Wang, Yunliang, Zhao, Hua, Wei, Feng, Zhang, Peng, Zhang, Xiying, Ren, Xiubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553570/
https://www.ncbi.nlm.nih.gov/pubmed/33101777
http://dx.doi.org/10.1080/2162402X.2020.1828538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553570/
https://www.ncbi.nlm.nih.gov/pubmed/33101777
http://dx.doi.org/10.1080/2162402X.2020.1828538

Ejemplares similares